Tower Research Capital LLC (Trc) Better Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.14 - $0.39 $59 - $165	-425 Reduced 1.86%	22,443 $4,000
Q3 2023 Nov 14, 2023	BUY	$0.34 - $1.23 $6,143 - $22,224	18,069 Added 376.52%	22,868 $8,000
Q2 2023 Aug 14, 2023	SELL	$0.69 - $1.46 $2,999 - $6,346	-4,347 Reduced 47.53%	4,799 $5,000
Q1 2023 May 09, 2023	BUY	$0.64 - $1.45 $1,687 - $3,822	2,636 Added 40.49%	9,146 $6,000
Q4 2022 Feb 10, 2023	SELL	$1.1 - $1.74 $419 - $662	-381 Reduced 5.53%	6,510 $7,000
Q3 2022 Nov 10, 2022	SELL	$1.53 - $2.77 $11,836 - $21,428	-7,736 Reduced 52.89%	6,891 $12,000
Q2 2022 Aug 15, 2022	BUY	$0.91 - $2.34 $13,140 - $33,789	14,440 Added 7721.93%	14,627 $23,000
Q1 2022 May 12, 2022	SELL	$1.98 - $5.01 $7,377 - $18,667	-3,726 Reduced 95.22%	187 $0
Q4 2021 Feb 14, 2022	BUY	$4.58 - $17.14 $17,921 - $67,068	3,913 New	3,913 $18,000

Ticker BTTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,743,000
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.